TMPRSS2-ERG Fusion Prostate Cancer: An Early Molecular Event Associated With Invasion

Andren, 2006, How well does the Gleason score predict prostate cancer death? A 20-year followup of a population based cohort in Sweden, J Urol, 175, 1337, 10.1016/S0022-5347(05)00734-2

Bismar, 2006, Defining aggressive prostate cancer using a 12-gene model, Neoplasia, 8, 59, 10.1593/neo.05664

Browne, 2004, Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens, Hum Pathol, 35, 1462, 10.1016/j.humpath.2004.09.009

Delattre, 1994, The Ewing family of tumors—a subgroup of small-round-cell tumors defined by specific chimeric transcripts, N Engl J Med, 331, 294, 10.1056/NEJM199408043310503

De Marzo, 1999, Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis, Am J Pathol, 155, 1985, 10.1016/S0002-9440(10)65517-4

Garraway, 2005, Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma, Nature, 436, 117, 10.1038/nature03664

Hofer, 2006, Prognostic factors in lymph node-positive prostate cancer, Urology, 67, 1016, 10.1016/j.urology.2005.10.055

Jemal, 2006, Cancer statistics, 2006, CA Cancer J Clin, 56, 106, 10.3322/canjclin.56.2.106

Johansson, 1992, High 10-year survival rate in patients with early, untreated prostatic cancer, JAMA, 267, 2191, 10.1001/jama.1992.03480160049033

Johansson, 1997, Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden, JAMA, 277, 467, 10.1001/jama.1997.03540300035030

Johansson, 2004, Natural history of early, localized prostate cancer, JAMA, 291, 2713, 10.1001/jama.291.22.2713

Luo, 2002, Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer, Cancer Res, 62, 2220

Mitelman, 2000, Recurrent chromosome aberrations in cancer, Mutat Res, 462, 247, 10.1016/S1383-5742(00)00006-5

Nakayama, 2003, Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection, Am J Pathol, 163, 923, 10.1016/S0002-9440(10)63452-9

Perner, 2006, TMPRSS2: ERG fusion associated deletions provide insight into the heterogeneity of prostate cancer, Cancer Res, 66, 8337, 10.1158/0008-5472.CAN-06-1482

Petrovics, 2005, Frequent overexpression of ETS-related gene-1 (ERG1) in prostate transcriptome, Oncogene, 24, 3847, 10.1038/sj.onc.1208518

Rubin, 2002, Alpha-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer, JAMA, 287, 1662, 10.1001/jama.287.13.1662

Rubin, 2004, Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer, Cancer Res, 64, 3814, 10.1158/0008-5472.CAN-03-3881

Rubin, 2005, Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death, Cancer Epidemiol Biomarkers Prev, 14, 1424, 10.1158/1055-9965.EPI-04-0801

Shah, 2001, Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?, Am J Pathol, 158, 1767, 10.1016/S0002-9440(10)64132-6

Tomlins, 2005, Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer, Science, 310, 644, 10.1126/science.1117679

Tomlins, 2006, TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer, Cancer Res, 66, 3396, 10.1158/0008-5472.CAN-06-0168

Weir, 2003, Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention and control, J Natl Cancer Inst, 95, 1276, 10.1093/jnci/djg040

Yoshimoto, 2006, Three-color FISH analysis of TMPRSS2/ERG fusions in prostate Cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement, Neoplasia, 8, 465, 10.1593/neo.06283